Phio shareholders approve reverse stock split (1:2-1:9) and 500K share increase to LTIP

Phio Pharmaceuticals Corp.

Reverse stock split proposal approved with 1,879,666 For, 313,572 Against; board to set exact ratio and effective date.
Amendment to 2020 Long Term Incentive Plan approved, increasing shares by 500,000 to total 725,500.
All five director nominees elected: Bitterman, Bradford, Ferrara, Freeman, Lockshin, each with >559K For votes.
Ratification of BDO USA as independent auditor for FY 2024 approved with 2,075,307 For votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.